The move will give 95 lower-income countries access to a generic version of Pfizer’s oral Covid-19 antiviral treatment.
35 Manufacturers Granted Licenses To Produce Generic Version Of Pfizer’s Covid Antiviral Pill For Developing Countries
The move will give 95 lower-income countries access to a generic version of Pfizer’s oral Covid-19 antiviral treatment.